Logo Image
Opinion|Videos|September 4, 2024

Safety and Efficacy of GnRHa Treatments in Central Precocious Puberty

The panel examines the efficacy and safety profiles of gonadotropin-releasing hormone analogue (GnRHa) treatments in managing Central Precocious Puberty.

Episodes in this series

Video content above is prompted by the following:

  • What are long-term efficacy and safety data associated with gonadotropin releasing hormone analogue (GnRHa) treatment?

Related Content

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?
Video

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

View more